Cargando…

Acute myeloid leukemia with 3q26 abnormality: An editorial perspective

Detalles Bibliográficos
Autor principal:	Ghosh, K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954817/ https://www.ncbi.nlm.nih.gov/pubmed/29692398 http://dx.doi.org/10.4103/jpgm.JPGM_255_17

Ejemplares similares

Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma
por: Leahey, Ann-Marie, et al.
Publicado: (2021)

Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)
por: Richard-Carpentier, Guillaume, et al.
Publicado: (2023)

Molecular characterization of the rare translocation t(3;10)(q26;q21) in an acute myeloid leukemia patient
por: Jancuskova, Tereza, et al.
Publicado: (2014)

3q26 chromosomal anomalies in acute myeloid leukemia: First descriptions from India
por: Gupta, A, et al.
Publicado: (2018)

Prognostic importance of the fusion partners and measurable residual disease in patients with acute myeloid leukemia who harbor 11q23/KMT2A alterations
por: Mrózek, Krzysztof
Publicado: (2023)

Chronic myeloid leukemia in India
por: Goldman, John M.
Publicado: (2013)

Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach
por: Arber, Daniel A., et al.
Publicado: (2022)

Tyrosine kinase domain mutations in chronic myelogenous leukemia patients: Indian perspective
por: Ghosh, K
Publicado: (2022)

Chronic myeloid leukemia: An Indian scenario
por: Digumarti, Raghunadharao
Publicado: (2016)

Editorial to the Special Issue “Recent Advances in Biochemical Mechanisms of Acute Myeloid Leukemia”
por: Mesuraca, Maria, et al.
Publicado: (2023)

Unbalanced chromosome 1 abnormalities leading to partial trisomy 1q in four infants with Down syndrome and acute megakaryocytic leukemia
por: Silva, Maria Luiza Macedo, et al.
Publicado: (2009)

Acute myeloid leukemia: leukemia stem cells write a prognostic signature
por: Gudgin, Emma J, et al.
Publicado: (2011)

Rewiring of the Transcription Factor Network in Acute Myeloid Leukemia
por: Assi, Salam A, et al.
Publicado: (2019)

Long non-coding RNAs emerge as a novel prognostic indicator in pediatric acute myeloid leukemia
por: Velasco-Hernandez, Talia, et al.
Publicado: (2023)

Chronic myeloid leukemia: Review of our Indian experience
por: Bhave, Abhay A.
Publicado: (2013)

Clinical Impact of Measurable Residual Disease in Acute Myeloid Leukemia
por: Azenkot, Tali, et al.
Publicado: (2022)

Derepression of retroelements in acute myeloid leukemia with 3q aberrations
por: Mika, Jagoda, et al.
Publicado: (2021)

Disrupting autophagy in FLT3-mutant acute myeloid leukemia
por: Grant, Steven
Publicado: (2022)

Diagnostic and Treatment Obstacles in Acute Myeloid Leukemia: Social, Operational, and Financial
por: Genç, Emine Eylem, et al.
Publicado: (2023)

Pediatric chronic myeloid leukemia with inv(3)(q21q26.2) and T lymphoblastic transformation: a case report
por: Lewen, Margaret, et al.
Publicado: (2016)

Fusion genes in acute myeloid leukemia: do acute myeloid leukemia diagnostics need to fuse with RNA-sequencing?
por: Thol, Felicitas
Publicado: (2022)

PB1815: ADDITIONAL СYTOGENETIC ABNORMALITIES IN ADULT ACUTE MYELOID LEUKEMIA WITH T(8;21)(Q22;Q22)
por: Zotova, Olena, et al.
Publicado: (2023)

Chronic Myeloid Leukemia Prognosis and Therapy: Criticisms and Perspectives
por: Russo, Domenico, et al.
Publicado: (2020)

Taking the STING out of acute myeloid leukemia through macrophage-mediated phagocytosis
por: Dalton, William Brian, et al.
Publicado: (2022)

Double inv(3)(q21q26.2) in acute myeloid leukemia is resulted from an acquired copy neutral loss of heterozygosity of chromosome 3q and associated with disease progression
por: Gu, Jun, et al.
Publicado: (2015)

Current treatment for pediatric acute myeloid leukemia
por: Im, Ho Joon
Publicado: (2018)

The Important Role of Immunotherapies in Acute Myeloid Leukemia
por: Greiner, Jochen
Publicado: (2019)

Pulling the Pin on NPMc(+) acute myeloid leukemia
por: Kats, Lev M.
Publicado: (2021)

Will immune therapy cure acute myeloid leukemia?
por: Gale, Robert Peter
Publicado: (2019)

Check(point) or checkmate for acute myeloid leukemia?
por: Niyongere, Sandrine, et al.
Publicado: (2021)

Editorial: Precision medicine for acute myeloid leukemia
por: Marconi, Giovanni, et al.
Publicado: (2023)

Targeting ncRNAs in the 3q26.2 amplicon
por: Chaluvally-Raghavan, Pradeep, et al.
Publicado: (2015)

TP53-mutant myelodysplastic syndrome and acute myeloid leukemia: the black hole of hematology
por: Patel, Shyam A., et al.
Publicado: (2022)

BETing on rational combination therapy in mutant FLT3 acute myeloid leukemia
por: Stone, Richard M.
Publicado: (2020)

Chronic myeloid leukemia data from India
por: Bansal, Shweta, et al.
Publicado: (2013)

Expanding dasatinib beyond KIT in acute myeloid leukemia
por: Welch, John S.
Publicado: (2020)

Time for Dynamic Assessment of Fitness in Acute Myeloid Leukemia
por: Palmieri, Raffaele, et al.
Publicado: (2022)

miRNAs as prognostic predictors in acute myeloid leukemia
por: Machado-Neto, João Agostinho, et al.
Publicado: (2023)

Immunotherapy with HDC/IL-2 may be clinically efficacious in acute myeloid leukemia of normal karyotype
por: Nilsson, Malin S., et al.
Publicado: (2019)

Proteomics: a new era in pediatric acute myeloid leukemia research
por: Lamba, Jatinder K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0k248a1549uk9fecju2naeb9ht